TELL ME MORE
ABOUT THIS CLINICAL TRIAL for ADHD in Children
An Open-Label, Safety Trial Evaluating an Investigational Medication Administered with Psychostimulants in Children and Adolescents (6 to 17 years of age) with ADHD
Clinical Trial for ADHD in Children
Study Location(s): Evansville, IN
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder affecting 11 percent of school-age children. Symptoms continue into adulthood in more than three-quarters of cases. ADHD is characterized by developmentally inappropriate levels of inattention, impulsivity and hyperactivity. This Open-Label, Safety Trial Evaluating and Investigational Medication Administered with Psychostimulants in Children and Adolescents (6 to 17 years of age) with Attention-Deficit/Hyperactivity Disorder (ADHD). Click here for more information on living with ADHD.
There is no cost to participate. Volunteers receive free investigational medicine and follow-up care. No insurance needed. Time and travel reimbursement up to $1500 may be available.
View More Studies
[table id=1 /]